VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Cited by
Items 401–500 of 1,013
Platelet-Derived Factors Involved in Tissue Repair—From Signal to Function
Mazzucco, L., Borzini, P., & Gope, R. (2010) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2010.03.004 · Cited by 108
Zhang, S., Cao, Z., Tian, H., Shen, G., Ma, Y., Xie, H., Liu, Y., Zhao, C., Deng, S., Yang, Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3109 · Cited by 101
ADAM9 Is Involved in Pathological Retinal Neovascularization
Guaiquil, V., Swendeman, S., Yoshida, T., Chavala, S., Campochiaro, P. A., & Blobel, C. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01460-08 · Cited by 94
“In addition, pathological neovascularization also has critical roles in other diseases such as cancer and rheumatoid arthritis (12, 14).”
BackgroundBlood Flow and Bmp Signaling Control Endocardial Chamber Morphogenesis
Dietrich, A.-C., Lombardo, V. A., Veerkamp, J., Priller, F., & Abdelilah‐Seyfried, S. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.06.020 · Cited by 113
“In most endothelial tissues, angiogenesis signaling involves vascular endothelial growth factors (VEGFs), their respective tyrosine kinase receptors (VEGFRs), and Notch signaling (de Vries et al., 1992; Olsson et al., 2006; Shibuya and Claesson-Welsh, 2006; Herbert and Stainier, 2011).”
BackgroundBrown, D. M., Heier, J. S., Ciulla, T. A., Benz, M. S., Abraham, P., Yancopoulos, G. D., Stahl, N., Ingerman, A., Vitti, R., Berliner, A. J., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.039 · Cited by 100
“Initially discovered s a vascular permeability factor, VEGF–A also decreases arrier functions of the endothelium, resulting in increased xtravasation of water and macromolecules.(10,11) Vascular”
BackgroundVascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension
Versmissen, J., Colafella, K. M. M., Koolen, S. L. W., & Danser, A. H. J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz022 · Cited by 109
Yang, H., Lv, D., Qu, S., Xu, H., Li, S., Wang, Z., Cao, X., Rong, Y., Li, X., Wu, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202403219 · Cited by 130
Heparan Sulfate Regulates VEGF165- and VEGF121-mediated Vascular Hyperpermeability
Xu, D., Fuster, M. M., Lawrence, R., & Esko, J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177006 · Cited by 112
Stahmann, N., Woods, A., Spengler, K., Heslegrave, A., Bauer, R., Krause, S., Viollet, B., Carling, D., & Heller, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108688 · Cited by 96
Dimberg, A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_21 · Cited by 102
“Several anti-angiogenic drugs, many of which disrupt VEGF/VEGFR activation, have been approved and are successfully used in the treatment of, for example, age-related macula degeneration and various types of cancer (Olsson et al. 2006; Jain et al. 2006).”
BackgroundMethodSelf-citationPrenatal Alcohol Exposure Affects Vasculature Development in the Neonatal Brain
Jégou, S., Ghazi, F. E., de Lendeu, P. K., Marret, S., Laudenbach, V., Uguen, A., Marcorelles, P., Roy, V., Laquerrière, A., & Gonzalez, B. J. (2012) · Annals of Neurology · doi:10.1002/ana.23699 · Cited by 100
“The biological functions of VEGFs are mediated by VEGF-R1, -R2, and -R3 receptors.(15) It has been reported that a single dose of alcohol (1.”
BackgroundTRPC1 Is Essential for In Vivo Angiogenesis in Zebrafish
Yu, P.-C., Gu, S.-Y., Bu, J.-W., & Du, J.-L. (2010) · Circulation Research · doi:10.1161/circresaha.109.207670 · Cited by 100
The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression
Gao, D., & Mittal, V. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.006 · Cited by 105
Srivastava, S. P., Hedayat, A. F., Kanasaki, K., & Goodwin, J. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00904 · Cited by 99
VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx
Ngok, S. P., Geyer, R., Liu, M., Kourtidis, A., Agrawal, S., Wu, C., Seerapu, H. R., Lewis-Tuffin, L. J., Moodie, K. L., Huveldt, D., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201207009 · Cited by 98
“HUVECs and HMVEC-dermal neonatal (Lonza) were TRCP1 (transient receptor potential canonical-1; Jho et al., 2005) and the subsequent activation of PKC- (Olsson et al., 2006).”
BackgroundMicrofluidic-based vascularized microphysiological systems
Lee, S., Ko, J., Park, D., Lee, S.-R., Chung, M., Lee, Y., & Jeon, N. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00285a · Cited by 91
Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells
Giampietro, C., Taddei, A., Corada, M., Sarra-Ferraris, G. M., Alcalay, M., Cavallaro, U., Orsenigo, F., Lampugnani, M. G., & Dejana, E. (2012) · Blood · doi:10.1182/blood-2011-09-381012 · Cited by 93
Sainson, R. C. A., & Harris, A. L. (2008) · Angiogenesis · doi:10.1007/s10456-008-9098-0 · Cited by 102
“VEGF-A, through the activation of the VEGFR2 receptor, is the most characterized mitogenic EC growth factor, and activates cell proliferation through the MAPK/ERK and PI3K/Akt pathways [48].”
BackgroundLakshmanan, R., Kumaraswamy, P., Krishnan, U. M., & Sethuraman, S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.033 · Cited by 100
The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease
Wen, Y.-D., Wang, H., & Zhu, Y. Z. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4010395 · Cited by 102
“To determine how H2S regulates endothelial functions, most studies focused on theVEGF (also called as vascular permeability factor, VPF) signaling, which is the arguably crucial pathway in angiogenic responses both under healthy and pathophysiological circumstances [173, 179].”
BackgroundElSheikh, R. H., Chauhan, M. Z., & Sallam, A. B. (2022) · Biomolecules · doi:10.3390/biom12111629 · Cited by 98
“PGF also attracts other inflammatory mediators, in turn stimulating the VEGFR-1 present on monocytes [5,6].”
BackgroundAnderson, S. M., Chen, T. T., Iruela‐Arispe, M. L., & Segura, T. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.05.030 · Cited by 96
“Vascular endothelial growth factor (VEGF) is a key component in the signaling cascade to form new blood vessels from existing vessels and can trigger proliferation, migration, and survival of cells through a single growth factor-receptor binding event [3].”
Vascular endothelial growth factor signaling in acute myeloid leukemia
Kampen, K. R., ter Elst, A., & de Bont, E. S. J. M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1085-3 · Cited by 102
“3) [48, 49].”
Targeted therapy in head and neck cancer
Kundu, S., & Nestor, M. (2012) · Tumor Biology · doi:10.1007/s13277-012-0350-2 · Cited by 116
“synergistic effect of bevacizumab in combination with chemotherapeutics agents [89].”
BackgroundIQGAP1-Dependent Signaling Pathway Regulates Endothelial Cell Proliferation and Angiogenesis
Meyer, R., Sacks, D. B., & Rahimi, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003848 · Cited by 95
“stimulation of VEGFR-2 provokes pleiotropic responses in endothelial cells including endothelial cell growth, survival, differentiation, migration, and tube formation [2].”
BackgroundNanomaterials for Angiogenesis in Skin Tissue Engineering
Cui, L., Liang, J., Liu, H., Zhang, K., & Li, J. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0337 · Cited by 96
“57 65–67 Besides, related signaling pathways include the PI3K/Akt pathway, the sarcoma pathway, P38MAPK, and so on.”
InfluentialSystems biology of pro‐angiogenic therapies targeting the VEGF system
Gabhann, F. M., Qutub, A. A., Annex, B. H., & Popel, A. S. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.92 · Cited by 95
“Possible pro-angiogenic targets: phosphatase inhibitors, signaling kinases— The complex web of intracellular signaling downstream of VEGF receptor activation has been the subject of many studies and reviews [69,83].”
BackgroundNovel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor β1
Clifford, R. L., Deacon, K., & Knox, A. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803342200 · Cited by 95
Gratzinger, D. A., Zhao, S., Tibshirani, R. J., Hsi, E. D., Hans, C. P., Pohlman, B. L., Bast, M. A., Avigdor, A., Schiby, G., Nagler, A., et al. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700697 · Cited by 100
Liu, H., Yu, S., Zhang, H., & Xu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046720 · Cited by 98
“VEGFR2 serves as the principal receptor for VEGF signaling [8] that leads to vasodilatation, endothelial cell migration, and proliferation [9].”
RetractedReece, K. M., Richardson, E. D., Cook, K. M., Campbell, T. J., Pisle, S. T., Holly, A. J., Venzon, D. J., Liewehr, D. J., Chau, C. H., Price, D. K., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-91 · Cited by 104
“Since there are several pathways and processes that regulate the production of VEGF protein [27,28], we could not definitively ascertain that the observed decrease in secreted VEGF was due to a decrease in HIF-1α activity.”
BackgroundZheng, L.-S., Wang, F., Li, Y.-H., Zhang, X., Chen, L.-M., Liang, Y.-J., Dai, C.-L., Yan, Y.-Y., Tao, L.-Y., Mi, Y.-J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005172 · Cited by 91
Histatins, wound healing, and cell migration
Torres, P., Castro, M., Reyes, M., & Torres, V. (2018) · Oral Diseases · doi:10.1111/odi.12816 · Cited by 90
Design of Growth Factor Sequestering Biomaterials
Belair, D. G., Le, N. N., & Murphy, W. (2014) · Chemical Communications · doi:10.1039/c4cc04317k · Cited by 89
Marušič, M., Veedu, R. N., Wengel, J., & Plavec, J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt697 · Cited by 94
“The latter approach resulted in the development of the first Food and Drug Administration (FDA)-approved aptamer drug, Macugen (Pegaptanib sodium), against age-related macular degeneration (13).”
BackgroundGorbunova, E. E., Gavrilovskaya, I. N., & Mackow, E. R. (2010) · Journal of Virology · doi:10.1128/jvi.00576-10 · Cited by 99
“mation, cell survival, and vascular permeability (5, 8, 10, 12, 33, 37, 43, 48, 51, 56, 60).”
BackgroundTime course of the angiogenic response during normotrophic and hypertrophic scar formation in humans
van der Veer, W. M., Niessen, F. B., Ferreira, J. A., Zwiers, P. J., de Jong, E. H., Middelkoop, E., & Molema, G. (2011) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2011.00692.x · Cited by 95
“considered to be instrumental for ECs to further engage in new sprout formation, as it has a direct effect on vascular permeability and temporary fibrin matrix formation, microvascular EC migration, proliferation, and survival.(7) In order to migrate and produce new capillaries, ECs furthermore up-regulate a variety o…”
BackgroundVEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer
Biselli-Chicote, P. M., Oliveira, A. R. C. P., Pavarino, É. C., & Goloni‐Bertollo, E. M. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1073-2 · Cited by 98
Building blood vessels—stem cell models in vascular biology
Jakobsson, L., Kreuger, J., & Claesson-Welsh, L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701146 · Cited by 93
“…early lethality of transgenic animals Inactivation of genes with a vascular function (vegfr2, vegfa, VE-cadherin, or pdgfrß) results in similar phenotypes in the EB model as in vivo, with regard to temporal effects on development and consequences for EC morphology (Table I) (Olsson et al., 2006).”
Self-citationExtracellular Matrix Stiffness Controls VEGF Signaling and Processing in Endothelial Cells
Sack, K. D., Teran, M., & Nugent, M. A. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25312 · Cited by 93
Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
Huang, W., Chen, W., & Zhang, X. (2016) · Oncology Letters · doi:10.3892/ol.2016.4952 · Cited by 103
“VEGF, a prominent pro-angiogenic factor and its receptor VEGF receptor 2 (VEGFR2), are highly expressed in glioblastomas and tumor vasculature (17,18).”
BackgroundAngiogenesis: A Target in Solid Tumors, Also in Leukemia?
Schmidt, T., & Carmeliet, P. (2011) · Hematology · doi:10.1182/asheducation-2011.1.1 · Cited by 92
Syed, F., Li, W., Relich, R. F., Russell, P. M., Zhang, S., Zimmerman, M. K., & Yu, Q. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab167 · Cited by 98
αB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis
Dimberg, A., Rylova, S. N., Dieterich, L. C., Olsson, A., Schiller, P., Wikner, C., Bohman, S., Botling, J., Lukinius, A., Wawrousek, E. F., et al. (2007) · Blood · doi:10.1182/blood-2007-04-087841 · Cited by 108
Self-citationThe influence of physical training on the angiopoietin and VEGF-A systems in human skeletal muscle
Gustafsson, T., Rundqvist, H., Norrbom, J., Rullman, E., Jansson, E., & Sundberg, C. J. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01103.2006 · Cited by 92
“The VEGF receptor (VEGFR)-2 is essential for most of the VEGF-mediated angiogenic actions (29, 30).”
BackgroundInfluentialHepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment
Zardi, E., Navarini, L., Sambataro, G., Piccinni, P., Sambataro, F., Spina, C., & Dobrina, A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990136 · Cited by 90
“VEGF activates multiple pathways such as mitogenactivated protein kinase (MAPK), focal adhesion kinase (FAK), phosphatidylinositol 3-kinase (PI3K/Akt), Phospholipase C- (PLC- ) [191].”
BackgroundGanta, V. C., Choi, M., Kutateladze, A. A., & Annex, B. H. (2016) · Circulation Research · doi:10.1161/circresaha.116.309516 · Cited by 96
“VEGF-A–mediated VEGFR2-signaling activation is largely viewed as the dominant receptor tyrosine kinase signaling to induce angiogenesis.(6,7) VEGFR1 plays important roles in several cardiovascular diseases including experimental PAD (10); however, the processes that regulate VEGFR1 activation or VEGFR1-specific downst…”
Jumping the barrier: VE‐cadherin, VEGF and other angiogenic modifiers in cancer
Le Guelte, A., Dwyer, J., & Gavard, J. (2011) · Biology of the Cell · doi:10.1042/bc20110069 · Cited by 91
“Although VEGF-A binds to both VEGF-R1 and -R2, only VEGF-R2 is implicated in every aspect of normal and pathological vascular permeability (Olsson et al., 2006).”
He, C., Wu, T., & Hao, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.098 · Cited by 91
NOTCH1 signaling induces pathological vascular permeability in diabetic retinopathy
Miloudi, K., Oubaha, M., Ménard, C., Dejda, A., Guber, V., Cagnone, G., Wilson, A. M., Tétreault, N., Mawambo, G., Binet, F., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814711116 · Cited by 93
Autocrine VEGF‐A/KDR loop protects epithelial ovarian carcinoma cells from anoikis
Sher, I., Adham, S. A., Petrik, J., & Coomber, B. L. (2008) · International Journal of Cancer · doi:10.1002/ijc.23963 · Cited by 95
“VEGF and its receptors are key regulators of the cardiovascular system, controlling angiogenesis, blood vessel permeability and lymphangiogenesis.(9) In different types of cancer including ovarian cancer, VEGF is over-expressed by the cancer cells, and facilitates tumor growth and metastasis by acting in a paracrine m…”
BackgroundMULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway
Lorenzon, E., Colladel, R., Andreuzzi, E., Marastoni, S., Todaro, F., Schiappacassi, M., Ligresti, G., Colombatti, A., & Mongiat, M. (2011) · Oncogene · doi:10.1038/onc.2011.487 · Cited by 90
“In particular, tyrosine 1175 (Tyr1175) and tyrosine 951 (Tyr951) phosphorylation have been shown to be primarily implicated in the regulation of EC migration (Olsson et al., 2006).”
BackgroundEdirisinghe, I., Yang, S., Yao, H., Rajendrasozhan, S., Caito, S. W., Adenuga, D., Wong, C. N., Rahman, A., Phipps, R. P., Jin, Z., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-099481 · Cited by 90
“KDR) to induce vascular permeability, cell proliferation, cellular migration, and tube formation in endothelial cells ( 1 ).”
BackgroundInfluentialHedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells
Hsieh, A., Ellsworth, R., & Hsieh, D. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22433 · Cited by 97
“VEGF constitutes a family of secreted and membrane bound proteins that prompt angiogenesis by inducing endothelial tube formation and proliferation (Olsson et al., 2006).”
BackgroundSato, T., Takeuchi, M., Karasawa, Y., Enoki, T., & Ito, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-19594-6 · Cited by 95
The tip cell concept 10 years after: New players tune in for a common theme
Siekmann, A. F., Affolter, M., & Belting, H. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.01.019 · Cited by 103
Mammalian phospholipase D: Function, and therapeutics
McDermott, M. I., Wang, Y., Wakelam, M. J. O., & Bankaitis, V. A. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.101018 · Cited by 93
Wang, Z., Wang, Y., Wang, Z., Gutkind, J. S., Wang, Z., Wang, F., Lu, J., Niu, G., Teng, G., & Chen, X. (2015) · Stem Cells · doi:10.1002/stem.1878 · Cited by 89
Zhang, X., Song, Y., Wu, Y., Dong, Y., Lai, L., Zhang, J., Lu, B., Dai, F., He, L., Liu, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25909 · Cited by 92
“Among three receptors (VEGFR1,2,3), VEGFR2 is the main receptor of VEGF involved in angiogenesis.(36) In our study, we found that the activity of VEGFR2 was inhibited by indiburin in a dose-dependent manner.”
BackgroundThe miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β
Sessa, R., Seano, G., di Blasio, L., Gagliardi, P. A., Isella, C., Médico, E., Cotelli, F., Bussolino, F., & Primo, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.07.011 · Cited by 102
“Interestingly, several evidences indicate that Tie-2 activation by Ang-1 requires PI3K to carry out any biological effect [44–46] while it is dispensable for several VEGF functions, such as proliferation, which are mediated by PLCγ and Ras [47].”
BackgroundTargeting endothelial and tumor cells with semaphorins
Bielenberg, D. R., & Klagsbrun, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9097-4 · Cited by 89
“[21]).”
Jha, A. K., Tharp, K. M., Browne, S., Ye, J., Stahl, A., Yeghiazarians, Y., & Healy, K. E. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.023 · Cited by 93
Chung, A. S., Kowanetz, M., Wu, X., Zhuang, G., Ngu, H., Finkle, D., Komuves, L., Peale, F., & Ferrara, N. (2012) · The Journal of Pathology · doi:10.1002/path.4052 · Cited by 87
The Role of Glypicans in Cancer Progression and Therapy
Li, N., Spetz, M. R., & Ho, M. (2020) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155420933709 · Cited by 92
Vascular endothelial growth factors in cardiovascular medicine
Testa, U., Pannitteri, G., & Condorelli, G. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283117d37 · Cited by 93
Gabhann, F. M., & Popel, A. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00637.2006 · Cited by 92
“VASCULAR ENDOTHELIAL GROWTH factor (VEGF) is a critical family of cytokines involved in the process of angiogenesis (or neovascularization), the outgrowth of new microvessels from existing vasculature (30, 36).”
BackgroundZhang, H., He, Y., Dai, S., Xu, Z., Luo, Y., Wan, T., Luo, D., Jones, D., Tang, S., Chen, H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36168 · Cited by 88
Pajares, M. J., Agorreta, J., Larráyoz, M., Vesin, A., Ezponda, T., Zudaire, I., Torre, W., Lozano, M. D., Brambilla, E. M., Brambilla, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.4231 · Cited by 88
Dynamic regulation of VEGF-inducible genes by an ERK-ERG-p300 transcriptional network
Fish, J. E., Gutierrez, M. E. C., Dang, L. T. H., Khyzha, N., Chen, Z., Veitch, S., Cheng, H. S., Khor, M., Antounians, L., Njock, M., et al. (2017) · Development · doi:10.1242/dev.146050 · Cited by 103
“VEGF activates a number of signal transduction pathways in endothelial cells (ECs) that modulate cytoskeletal dynamics and gene expression (Olsson et al., 2006), resulting in a suite of angiogenic cell behaviors, including directed, polarized cell migration.”
BackgroundMünch, V., Trentin, L., Herzig, J., Demir, S., Seyfried, F., Kraus, J. M., Kestler, H. A., Köhler, R., Barth, T. F. E., Kronnie, G. T., et al. (2017) · Blood · doi:10.1182/blood-2017-03-769315 · Cited by 98
The role of different VEGF isoforms in scar formation after glaucoma filtration surgery
Bergen, T. V., Vandewalle, E., de Veire, S. V., Dewerchin, M. A., Stassen, J., Moons, L., & Stalmans, I. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.08.016 · Cited by 93
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Xue, Y., Ruan, Y., Wang, Y., Xiao, P., & Xu, J. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00184-0 · Cited by 97
Pons, M., & Marin‐Castaño, M. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016722 · Cited by 93
“VEGF regulates endothelial cells proliferation, migration and survival [50].”
BackgroundAngiogenic Signalling Pathways
Ahmed, Z., & Bicknell, R. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-241-0_1 · Cited by 81
VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle
Gabhann, F. M., Ji, J. W., & Popel, A. S. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00800.2006 · Cited by 95
Platelet-derived growth factor receptor-β promotes early endothelial cell differentiation
Rolny, C., Nilsson, I., Magnusson, P. U., Armulik, A., Jakobsson, L., Wentzel, P., Lindblom, P., Norlin, J., Betsholtz, C., Heuchel, R. L., et al. (2006) · Blood · doi:10.1182/blood-2006-04-014894 · Cited by 87
Endorepellin Evokes Autophagy in Endothelial Cells
Poluzzi, C., Casulli, J., Goyal, A., Mercer, T. J., Neill, T., & Iozzo, R. V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556530 · Cited by 85
“Following engagement, endorepellin seemingly attenuates VEGFR2 phosphorylation at Tyr(1175), a key residue from which the phospholipase C- signaling cascade originates (93).”
BackgroundAlmalki, S. G., & Agrawal, D. K. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0568-4 · Cited by 86
“The binding of VEGF-A to VEGFR2 phosphorylates PLC-γ, and activates the MAPK/ERK and p38 MAPK signaling pathways [9, 18].”
BackgroundZhang, W., Xiong, Z., Wei, T., Li, Q., Tan, Y. C., Li, L., & Feng, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0334-2 · Cited by 90
Vascularization of Engineered Teeth
Lechguer, A. N., Kuchler‐Bopp, S., Hu, B., Haïkel, Y., & Lesot, H. (2008) · Journal of Dental Research · doi:10.1177/154405910808701216 · Cited by 86
“It is the earliest marker of angioblast precursors, endothelial and hematopoietic cells (Coultas et al., 2005; Olsson et al., 2006).”
BackgroundLaw, A. Y. S., & Wong, C. K. C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.024 · Cited by 94
“As regards to VEGF-triggered angiogenic responses, two major kinds of VEGF receptors VEGFR1 (flt-1) and VEGFR2 (KDR/Flk-1) are involved (Olsson et al., 2006).”
Mazor, R., Alsaigh, T., Shaked, H., Altshuler, A. E., Pocock, E. S., Kistler, E. B., Karin, M., & Schmid‐Schönbein, G. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417451 · Cited by 86
Varone, E., Decio, A., Chernorudskiy, A. L., Minoli, L., Brunelli, L., Ioli, F., Piotti, A., Pastorelli, R., Fratelli, M., Gobbi, M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01659-y · Cited by 93
“endothelial cell migration/proliferation and de novo vessel formation [5, 6].”
BackgroundGirling, J. E., & Rogers, P. A. W. (2009) · Reproduction · doi:10.1530/rep-09-0147 · Cited by 93
“Negative regulation of VEGFA is also provided by a soluble form of VEGFR1 (sFLT1), which binds to VEGFA preventing binding with VEGFR2 (Olsson et al. 2006).”
BackgroundInfluentialHao, Q., Wang, L., & Tang, H. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00504.2008 · Cited by 90
“THE CENTRAL ROLES of vascular endothelial growth factor (VEGF, also termed VEGF-A) and the bioactive VEGF receptor 2 (VEGFR2, also termed Flk-1 or KDR) in vascular development during embryogenesis and angiogenesis in the adult have been well documented (24).”
BackgroundLoss of Endothelial Tie1 Receptor Impairs Lymphatic Vessel Development-Brief Report
D'Amico, G., Korhonen, E. A., Waltari, M., Saharinen, P., Laakkonen, P., & Alitalo, K. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.196618 · Cited by 87
The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer
Zhu, X., & Zhou, W. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00159 · Cited by 84
“In humans, there are at least three VEGF receptors, VEGFR-1 (20, 21), VEGFR-2 (22), and VEGFR-3 (6, 23).”
BackgroundNotch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy
Gu, J.-W., Rizzo, P., Pannuti, A., Golde, T., Osborne, B., & Miele, L. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-7 · Cited by 80
“VEGFR2 regulates most of the endothelial cell response to VEGF-A, including cell migration, proliferation, survival, permeability and sprouting of new blood vessels from pre-existing ones [19].”
Sadremomtaz, A., Mansouri, K., Alemzadeh, G., Safa, M., Rastaghi, A. R. E., & Asghari, S. M. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.08.013 · Cited by 88
Ghorab, M. M., Alsaid, M. S., Soliman, A. M., & Ragab, F. A.-F. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1334650 · Cited by 83
“4-(2-(2-(2-(3-Fluoro-4-methylbenzylidene)hydrazinyl)-2-oxoethylthio)4-oxobenzo[g]quinazolin-3(4H)-yl)benzenesulfonamide (7) Yield, 82%; m.”
VEGF signaling regulates the fate of obstructed capillaries in mouse cortex
Reeson, P. L., Choi, K. J., & Brown, C. E. (2018) · eLife · doi:10.7554/elife.33670 · Cited by 88
“We focused on Vascular Endothelial Growth Factor Receptor 2 (VEGF-R2) signaling given that it is a critical regulator of endothelial cell function and is very sensitive to changes in hemodynamic shear stress (Olsson et al., 2006; Tzima et al., 2005).”
BackgroundIoannidou, E., Moschetta, M., Shah, S., Parker, J. S., Öztürk, M. A., Pappas‐Gogos, G., Sheriff, M., Rassy, E., & Boussios, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189926 · Cited by 87
Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive
Franco, M., & Tamagnone, L. (2008) · EMBO reports · doi:10.1038/embor.2008.139 · Cited by 79
“…is an unusual rtK that is devoid of catalytic activity, VEgFr2 is known to activate intracellular signalling pathways, including plcγ and pi(3)K/aKt (olsson et al, 2006). the mechanisms that mediate the activation of plexin-associated tyrosine kinases in response to semaphorin stimulation have…”
BackgroundNew Role for the Protein Tyrosine Phosphatase DEP-1 in Akt Activation and Endothelial Cell Survival
Chabot, C., Spring, K., Gratton, J., Elchebly, M., & Royal, I. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01374-08 · Cited by 95
“Thus, although VEGFR2 autophosphorylation sites known to be involved in the activation of all of these pathways were upregulated in DEP-1-depleted cells (5, 41), 244 CHABOT ET AL.”
BackgroundZhuang, G., Yu, K., Jiang, Z., Chung, A., Yao, J., Ha, C., Toy, K., Soriano, R., Haley, B., Blackwood, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003572 · Cited by 80
Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo
Jung, S.-K., Lee, K. W., Byun, S., Lee, E. J., Kim, J. E., Bode, A. M., Dong, Z., & Lee, H. J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp221 · Cited by 83
Fully quantified spectral imaging revealsin vivomembrane protein interactions
King, C., Stoneman, M. R., Raicu, V., & Hristova, K. A. (2016) · Integrative Biology · doi:10.1039/c5ib00202h · Cited by 93
Xu, Y., Yang, Q., Liu, T., Li, K., Liu, Y., Zhu, C., Zhang, Z., Li, L., Zhang, C., Xie, M., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.054 · Cited by 87
The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling
Mattila, E., Auvinen, K., Salmi, M., & Ivaska, J. (2008) · Journal of Cell Science · doi:10.1242/jcs.031898 · Cited by 83
“2001), although VEGF does not seem to be a powerful mitogen for endothelial cells (Olsson et al., 2006).”
BackgroundInfluentialKim, G. D., Oh, J., Park, H.-J., Bae, K., & Lee, S. K. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1959 · Cited by 82
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.